American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Health Disorders, 4th edn.
Washington, DC: American Psychiatric Association.
et al. (2013). Cognitive and affective predictors of subjective memory complaints in the Australian Imaging Biomarkers and Lifestyle (AIBL) study of aging: a cross-sectional analysis. International Psychogeriatrics, 7, S239.
Craig, C. L.
et al. (2003). International physical activity questionnaire: 12-country reliability and validity. Medicine and Science in Sports and Exercise, 35, 1381–1395.
Delis, D., Kramer, J., Kaplan, E. and Ober, B. (2000). California Verbal Learning Test-Second Edition. San Antonio, TX: The Psychological Corporation.
Delis, D. C., Kaplan, E. and Kramer, J. H. (2001). The Delis-Kaplan Executive Function System (D-KEFS). San Antonio, TX: The Psychological Corporation.
Ellis, K. A.
et al. (2009). The Australian Imaging Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease. International Psychogeriatrics, 21, 672–687.
Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975). “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.
Jorm, A. F. and Jacomb, P. A. (1989). The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychological Medicine, 19, 1015–1022.
Kurz, A. and Lautenschlager, N. L. (2010). Established treatements for Alzheimer's disease: cholinesterase inhibitors and memantine. In Ames, D., Burns, A. and O'Brien, J. (eds.), Dementia, 4th edn. (pp. 471–483). London: Hodder.
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939–944.
Mewton, L., Sachdev, P., Anderson, T., Sunderland, M. and Andrews, G. (2013). Demographic, clinical, and lifestyle correlates of subjective memory complaints in the Australian population. American Journal of Geriatric Psychiatry, doi: 10.1016/j.jagp.2013.04.004.
Meyers, J. E. and Meyers, K. R. (1995). Rey Complex Figure Test and Recognition Trial: Professional Manual. Lutz, FL: Psychological Assessment Resource, Inc.
Morris, J. C. (1993). The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology, 43, 2412–2414.
Morris, J. C.
et al. (2012). Developing an international network for Alzheimer research: the Dominantly Inherited Alzheimer Network. Clinical Investigation (London), 2, 975–984.
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G. and Kokmen, E. (1999). Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology, 56, 303–308.
Reiman, E. M.
et al. (2011). Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments. Journal of Alzheimer's Disease, 26, 321–329.
Rowe, C. C.
et al. (2010). Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Imaging beta-amyloid burden in aging and dementia. Neurobiology of Aging, 31, 1275–1283.
Savage, G. (2010). Neuropsychological assessment of dementia. In Ames, D., Burns, A. and O'Brien, J. (eds.), Dementia, 4th edn. (pp. 61–67). London: Hodder.
et al. (2000). Normative data on the Boston Naming Test and two equivalent 30-item short forms. Clinical Neuropsychology, 14, 526–534.
Schneider, L. S., Insel, P. S., Weiner, M. W. and the Alzheimer's Disease Neuroimaging Initiative (2011). Treatment with cholinesterase inhibitors and memantine in patients in the Alzheimer's Disease Neuroimaging Initiative. Archives of Neurology, 68, 58–66.
Sheikh, J. I. and Yesavage, J. A. (1986). Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. In Clinical Gerontology: Guide to Assessment and Intervention (pp. 165–173). New York: The Haworth Press.
Slavin, M. J.
et al. (2010). Prevalence and predictors of “subjective cognitive complaints” in the Sydney Memory and Ageing Study. American Journal of Geriatric Psychiatry, 18, 701–710.
Snaith, R. P. and Zigmond, A. S. (1986). The hospital anxiety and depression scale. British Medical Journal (Clinical Research Ed.), 292, 344.
et al. (2012). Predictors of rapid decline in Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of ageing. International Psychogeriatrics, 24, 197–204.
Sperling, R. A.
et al. (2011). Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers & Dementia, 7, 280–292.
Strauss, E., Sherman, E. M. S. and Spreen, O. (2006). A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary, 3rd edn.
New York: Oxford University Press.
Wechsler, D. (1945). A standardised memory scale for clinical use. Journal of Psychology, 19, 87–95.
Wechsler, D. (1997). Wechsler Adult Intelligence Scale–Third Edition (WAIS-III). San Antonio, TX: The Psychological Corporation.
Wechsler, D. (2001). Wechsler Test of Adult Reading: Examiner's Manual. San Antonio, Texas: The Psychological Corporation.
et al. (2004). Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine, 256, 240–246.
World Health Organization (1992). ICD-10 Classifications of Mental and Behavioural Disorder: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization.
Zigmond, A. S. and Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67, 361–370.